BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30652650)

  • 1. Tetrahydrocurcumin, Curcumin, and 5-Fluorouracil Effects on Human Esophageal Carcinoma Cells.
    Pendleton EG; Jamasbi RJ; Geusz ME
    Anticancer Agents Med Chem; 2019; 19(8):1012-1020. PubMed ID: 30652650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway].
    Tian F; Song M; Xu PR; Liu HT; Xue LX
    Ai Zheng; 2008 Jun; 27(6):566-70. PubMed ID: 18570726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
    Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F
    Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
    Chen Q; Hou J; Wu Z; Zhao J; Ma D
    Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics.
    Zhang C; Ma Q; Shi Y; Li X; Wang M; Wang J; Ge J; Chen Z; Wang Z; Jiang H
    Oncol Rep; 2017 May; 37(5):2942-2954. PubMed ID: 28393186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of curcumin and 5-fluorouracil in cancer therapy.
    Wei Y; Yang P; Cao S; Zhao L
    Arch Pharm Res; 2018 Jan; 41(1):1-13. PubMed ID: 29230689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.
    Lin K; Jiang H; Zhuang SS; Qin YS; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
    FASEB J; 2019 Feb; 33(2):1972-1988. PubMed ID: 30226808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
    Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
    Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines.
    Almanaa TN; Geusz ME; Jamasbi RJ
    BMC Complement Altern Med; 2012 Oct; 12():195. PubMed ID: 23095512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147.
    Yin Z; Cai H; Wang Z; Jiang Y
    Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma.
    Mizumoto A; Ohashi S; Kamada M; Saito T; Nakai Y; Baba K; Hirohashi K; Mitani Y; Kikuchi O; Matsubara J; Yamada A; Takahashi T; Lee H; Okuno Y; Kanai M; Muto M
    J Gastroenterol; 2019 Aug; 54(8):687-698. PubMed ID: 30737573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.
    Shakibaei M; Buhrmann C; Kraehe P; Shayan P; Lueders C; Goel A
    PLoS One; 2014; 9(1):e85397. PubMed ID: 24404205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells.
    Zhao H; Liu Q; Wang S; Dai F; Cheng X; Cheng X; Chen W; Zhang M; Chen D
    Cancer Med; 2017 Jul; 6(7):1698-1706. PubMed ID: 28573788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma.
    Tung LN; Song S; Chan KT; Choi MY; Lam HY; Chan CM; Chen Z; Wang HK; Leung HT; Law S; Huang Y; Song H; Lee NP
    Cancer Res Treat; 2018 Oct; 50(4):1362-1377. PubMed ID: 29361818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma.
    Liu Y; Wang X; Zeng S; Zhang X; Zhao J; Zhang X; Chen X; Yang W; Yang Y; Dong Z; Zhu J; Xu X; Tian F
    J Exp Clin Cancer Res; 2018 Dec; 37(1):303. PubMed ID: 30518397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.